SCHEMBL30065579

SCHEMBL30065579

CON(C)C(=O)C1C(O[Si](c2ccccc2)(c2ccccc2)C(C)(C)C)CCN1C(=O)O

nearest known ligand 0.35

Predicted protein targets (top 3)

geneUniProtsupporting neighboursconfidence
RIPK1 Q13546 3/20 0.33
MCL1 Q07820 2/20 0.32
GRM5 P41594 2/20 0.31

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL22555283 1.00 RIPK1 (0.33) RIPK1MCL1GRM5
SCHEMBL30070935 0.90 USP30 (0.37) GRM5
SCHEMBL26694476 0.86 RIPK1 (0.37) RIPK1
SCHEMBL23043370 0.86 RIPK1 (0.37) RIPK1
SCHEMBL4120850 0.86 RIPK1 (0.37) RIPK1
SCHEMBL29889630 0.85 KMT2A (0.36) RIPK1
SCHEMBL22554958 0.85 RIPK1 (0.36) RIPK1
SCHEMBL30065094 0.85 RIPK1 (0.36) RIPK1
SCHEMBL4105456 0.78 RIPK1 (0.37) RIPK1
SCHEMBL2645429 0.77 UCHL1 (0.39) MCL1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-4087573-A1 KRAS G12C INHIBITORS Mirati Therapeutics, Inc. (US) 2022-11-16 EP disclosed